Acute and Subacute Toxicity Assessment of Oxyclozanide in Wistar Rats
Open Access
- 6 September 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 6, 294
Abstract
Oxyclozanide is an effective anthelmintic and has shown good properties in other ways including anti-adenovirus, anti-biofilm, antifungal, and antibacterial activity. This study aimed to investigate the acute and subacute 28-days repeated dose oral toxicity of an oxyclozanide suspension in Wistar rats. A high oral lethal dose (LD50) of 3,707 mg/kg was observed in the acute toxicity test. During the 28-days time period, no obvious adverse effects or death were detected. Histopathological changes were observed in the heart, liver, and kidney of animals treated with high dose of oxyclozanide. Based on the hematological parameters, there were no statistical differences between the oxyclozanide-treated group and the control group. For biochemistry assays, ALP, AST, GLU, TBIL, GLO, TG, BUN, UA, LDH, and CK were statistically changed in the treatment groups. These data suggested that the LD50 of oxyclozanide was ~3,707 mg/kg body weight (BW), and the lowest observed adverse effect level (LOAEL) of oxyclozanide was at a dose of 74 mg/kg in rats.Keywords
This publication has 35 references indexed in Scilit:
- The Role of Bilirubin in Diabetes, Metabolic Syndrome, and Cardiovascular DiseasesFrontiers in Pharmacology, 2012
- Rifampicin Does not Significantly Affect the Expression of Small Heterodimer Partner in Primary Human HepatocytesFrontiers in Pharmacology, 2012
- Effects of divergent selection for serum insulin-like growth factor-I concentration on performance, feed efficiency, and ultrasound measures of carcass composition traits in Angus bulls and heifersJournal of Animal Science, 2008
- Molecular Modelling Analysis of the Metabolism of ZebularineJournal of Pharmacology and Toxicology, 2006
- Spontaneous and Drug-Induced Hepatic Pathology of the Laboratory Beagle Dog, the Cynomolgus Macaque and the MarmosetToxicologic Pathology, 2005
- Activity of oxyclozzanide, nitroxynil, clorsulon and albendazole against adult triclabendazole resistant Fasciola hepaticaVeterinary Record, 2001
- Wirksubstanzen der Pflanzenschutz- und SchädlingsbekämpfungsmittelJournal of Pest Science, 1996
- Susceptibility to genotoxic effects of niclosamide in human peripheral lymphocytes exposed in vitro and in vivoMutation Research Letters, 1986
- A New Drug for the Treatment of Fascioliasis in Sheep and CattleNature, 1966
- Oxyclozanide (3,3',5,5',6-pentachloro-2,2'-dihydroxybenzanilide--6Zanil") in the treatment of the liver fluke Fasciola hepatica in sheep and cattleVeterinary Record, 1966